Compounds > 1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin
Page last updated: 2024-09-03

1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin and Leukemia, Myeloid

1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin has been researched along with Leukemia, Myeloid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berdel, WE; Danhauser-Riedl, S; Hong, CI; Okamoto, S; Rastetter, J; Vogler, WR; West, CR; Winton, EF1

Other Studies

1 other study(ies) available for 1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin and Leukemia, Myeloid

ArticleYear
Therapeutic activity of 1-beta-D-arabinofuranosylcytosine conjugates of lipids in WEHI-3B leukemia in mice.
    Experimental hematology, 1989, Volume: 17, Issue:4

    Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cytarabine; Drug Administration Schedule; Female; Injections, Intraperitoneal; Leukemia, Myeloid; Mice; Mice, Inbred BALB C; Neoplasm Transplantation

1989